

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | CK-666 is a potent inhibitor of the Arp2/3 complex, an actin-related protein, displaying an IC50 value of 12 μM. By binding to the Arp2/3 complex, CK-666 stabilizes its inactive form and prevents the movement of Arp2 and Arp3 subunits into an activated, filament-like conformation[1].[2]. |
| Concentration | Treated Time | Description | References | |
| Pfa1 cells | 100 μM | 72 h | CK-666 significantly mitigated tamoxifen-induced ferroptosis | J Biol Chem. 2024 Dec;300(12):107942. |
| 293T cells | 100 μM | 24 h | CK-666 significantly mitigated RSL3-induced ferroptosis | J Biol Chem. 2024 Dec;300(12):107942. |
| BJ fibroblasts | 100 μM | 24 h | CK-666 significantly mitigated RSL3-induced ferroptosis | J Biol Chem. 2024 Dec;300(12):107942. |
| bone marrow-derived macrophages | 100 µM | Study the effects of CK-666 and CK-869 on macrophage phagocytosis and motility. CK-869 significantly impacted phagocytosis and cell migration, while CK-666 had no discernible effect. | EMBO Rep. 2024 Aug;25(8):3221-3239 | |
| HeLa cells | 50, 100, 200, 300 µM | 60 min | Investigate the effects of CK-666 and CK-869 on vaccinia virus-induced actin polymerization. CK-869 nearly completely inhibited virus-induced actin assembly, while CK-666 reduced actin polymerization by ~30% even at 300 µM. | EMBO Rep. 2024 Aug;25(8):3221-3239 |
| Ptk2 cells | 100 μM | To study the effect of CK-666 on L. monocytogenes motility in Ptk2 cells, results showed immediate cessation of bacterial movement and disintegration of comet tails upon CK-666 treatment | mBio. 2018 Apr 10;9(2):e02259-17 | |
| HeLa cells | 100 μM | To study the effect of CK-666 on L. monocytogenes motility in HeLa cells, results showed immediate cessation of bacterial movement and disintegration of comet tails upon CK-666 treatment | mBio. 2018 Apr 10;9(2):e02259-17 | |
| Human trabecular meshwork cells | 100 μM | 24 h | CK-666 significantly reduced the number and length of filopodia on the surface of TM cells and decreased the transfer of fluorescently labeled vesicles. | Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5298-5307 |
| HT1080 cells | 100 μM | 24 h | CK-666 significantly mitigated ferroptosis induced by both RSL3 and erastin | J Biol Chem. 2024 Dec;300(12):107942. |
| human brain microvascular endothelial cells (hCMEC/D3 cells) | 80 μM | 1 hour | Inhibition of Arp2/3 complex activity protected against METH-induced enhanced F-actin formation and occludin internalization | J Biol Chem. 2013 Nov 15;288(46):33324-34 |
| Mouse embryonic fibroblasts (IA32) | 150 µM | 2 h | Used to synchronize lamellipodia in cells, CK-666 treatment caused complete loss of lamellipodia, which regrew upon drug washout | J Cell Biol. 2015 Jun 22;209(6):803-12 |
| Arabidopsis epidermal cells | 10 µM | 5 min | Inhibits Arp2/3 complex activity, significantly reducing the frequency of side-branched nucleation events and overall actin filament abundance | Plant Cell. 2024 Feb 26;36(3):764-789 |
| Administration | Dosage | Frequency | Description | References | ||
| C57BL/6 mice | Renal ischemia-reperfusion injury model | Intraperitoneal injection | 30 mg/kg | 24 hours and 2 hours before surgery | CK-666 significantly ameliorated renal ischemia-reperfusion injury and ferroptosis | J Biol Chem. 2024 Dec;300(12):107942. |
| C57BL/6 mice | METH-induced blood-brain barrier disruption model | Intraperitoneal injection | 5 mg/kg | Single dose, lasting 1 hour | Pretreatment with CK-666 attenuated METH-induced decrease in occludin levels in brain microvessels and increased BBB permeability | J Biol Chem. 2013 Nov 15;288(46):33324-34 |
| Arabidopsis | Arabidopsis epidermal cells | Solution treatment | 10 µM | Single treatment, lasting 5 minutes | Acutely inhibits Arp2/3 complex activity, mimicking the phenotypes of arp2/3 mutants, reducing actin filament abundance and side-branched nucleation events | Plant Cell. 2024 Feb 26;36(3):764-789 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.37mL 0.67mL 0.34mL |
16.87mL 3.37mL 1.69mL |
33.75mL 6.75mL 3.37mL |
|
| CAS号 | 442633-00-3 |
| 分子式 | C18H17FN2O |
| 分子量 | 296.34 |
| SMILES Code | CC(NC1=CC=CC=C21)=C2CCNC(C3=C(F)C=CC=C3)=O |
| MDL No. | MFCD03036271 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | UXRKUKRXVWJFER-UHFFFAOYSA-N |
| Pubchem ID | 589075 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 120 mg/mL(404.94 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1